SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.360
0.00 (0.00%)
Jul 31, 2026, 4:08 PM HKT
SinoMab BioScience Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -104.99 | -185.14 | -243.11 | -284.16 | -288.19 |
Depreciation & Amortization | 26.5 | 29.03 | 34.77 | 27.03 | 20.32 |
Other Amortization | 0.85 | 1.25 | 1.29 | 1 | 0.34 |
Loss (Gain) From Sale of Assets | -7.41 | - | -1.24 | 1.44 | - |
Asset Writedown & Restructuring Costs | - | - | - | 1.48 | - |
Loss (Gain) From Sale of Investments | -0.73 | -0.5 | 0.51 | -39.43 | -1.34 |
Loss (Gain) on Equity Investments | - | - | - | 5.4 | 4.29 |
Stock-Based Compensation | 7.12 | 6.82 | 19 | 5.02 | 62.9 |
Other Operating Activities | 5.53 | 18.38 | 6.58 | 4.96 | 7.99 |
Change in Accounts Payable | -4.34 | 1.71 | -12.31 | -10.84 | 34 |
Change in Other Net Operating Assets | 6.99 | -2.35 | 60.66 | -12.44 | 12.64 |
Operating Cash Flow | -70.48 | -130.8 | -133.85 | -300.54 | -147.06 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -25.03 | -41.17 | -103.34 | -112.75 | -198.23 |
Sale of Property, Plant & Equipment | 0.49 | 0.04 | 0.01 | - | - |
Sale (Purchase) of Intangibles | -0.28 | -0.33 | -0.55 | -1.63 | -16.69 |
Investment in Securities | -3.93 | -13.03 | 0.11 | 33.93 | 75.87 |
Other Investing Activities | 44.99 | -39.99 | 6.86 | -0.9 | 1.34 |
Investing Cash Flow | 16.25 | -94.48 | -96.92 | -81.36 | -137.7 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 30.2 | 97.37 | 124.19 | 71.76 | 143.32 |
Total Debt Issued | 30.2 | 97.37 | 124.19 | 71.76 | 143.32 |
Long-Term Debt Repaid | -122.82 | -73.25 | -43.73 | -10.57 | -21.44 |
Total Debt Repaid | -122.82 | -73.25 | -43.73 | -10.57 | -21.44 |
Net Debt Issued (Repaid) | -92.62 | 24.12 | 80.46 | 61.19 | 121.88 |
Issuance of Common Stock | 428.19 | 54.85 | 10.04 | 46.09 | - |
Repurchase of Common Stock | - | - | - | - | -59.67 |
Other Financing Activities | -6.18 | -5.7 | -8.23 | -4.99 | -4.69 |
Financing Cash Flow | 329.39 | 73.27 | 82.27 | 102.29 | 57.52 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -14.35 | 10.25 | 9.28 | 59.52 | -20.14 |
Net Cash Flow | 260.81 | -141.76 | -139.22 | -220.1 | -247.39 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -95.5 | -171.97 | -237.19 | -413.29 | -345.3 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | - | -8487.96% | -17376.19% | -10250.22% | -1295.33% |
Free Cash Flow Per Share | -0.08 | -0.16 | -0.23 | -0.42 | -0.35 |
Levered Free Cash Flow | -28.55 | -176.4 | -246.47 | -209.19 | -272.87 |
Unlevered Free Cash Flow | -25.1 | -170.98 | -242.35 | -206.09 | -269.23 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 6.18 | 5.7 | 8.23 | 4.99 | 4.69 |
Change in Working Capital | 2.65 | -0.64 | 48.34 | -23.27 | 46.64 |